Vaccination reduces transmission to unvaccinated household members by 63% for Delta variant Vaccination protects against COVID-19, and also reduces the risk of transmitting the virus to others.
RIVM recommends limiting number of e-cigarettes flavourings to 23 with tobacco taste only The government wishes to make e-cigarettes less attractive, in particular for young people.
4 in 5 COVID-19 patients in ICU are not vaccinated 4 in 5 COVID-19 patients in intensive care are not vaccinated against the coronavirus SARS-CoV-2.
Expected autumn increase in SARS-CoV-2 appears to have started In the past week from 5-12 October 2021, the reported number of people who tested positive for COVID-19 increased by 48% compared to the previous week. Reported figures increased in all regions and in all age groups.
More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Specific group of patients with impaired immunity invited in October for third COVID-19 vaccination From 6 October on, a specific group of people with severely impaired immunity (immunocompromised patients) will receive their invitation for a third vaccination against COVID-19.
Less air pollution from traffic and industry but increased contribution from agriculture International air policy has shown good results in Europe: in the past 35 years the air has become cleaner. Nevertheless air pollution is still an important cause of premature death.
Early detection of work-related health risks in Europe At European level, different methods are used to identify substances and processes that may cause cancer as early as possible, the so-called early warning systems.
Burden of disease and societal costs of work-related cancer in the European Union Yearly approximately 122,600 people in the EU are diagnosed with cancer, caused by past exposure to carcinogenic substances at work.